Biopsy

A prostate biopsy, also known as a core needle biopsy or a transrectal ultrasound (TRUS), is used to determine if any suspicious looking tissues are cancerous or not. A biopsy is conducted when an abnormal lump is found during a digital rectal exam (DRE) or if the prostate-specific antigen (PSA) blood test reveals high levels of PSA.

Prostate Cancer Canada graciously acknowledges the Princess Margaret Cancer Centre for sharing this video with us.
 
How is a biopsy performed?
  • You will be given a local anesthetic. 
  • A biopsy needle and ultrasound probe is then inserted into your rectum. Your doctor will use the ultrasound as a visual aid to help him/her guide the needle through your rectum. The needle quickly pierces through the rectal wall, enters the prostate and removes a tissue sample.
  • 8-12 samples will be taken depending on the area to be examined.
  • Procedure lasts between 15 and 20 minutes. 
What can I expect after the procedure?
 
Everyone responds differently to procedures. Following a prostate biopsy, it is common to experience the following:
  • Bleeding from your rectum or penis
  • Blood in the stool, urine or semen
  • Pain
These common symptoms may persist for 2 weeks or more. If you have concerns about these symptoms, discuss them with your doctor.


 

For more information and support:





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada Partners with Screw Cancer™

TORONTO, ON - Starting today, you can screw cancer and give hope in your local community by purchasing the Screw Cancer™ screwdriver in support of Prostate Cancer Canada.
More

Indy Cycling Challenge at Exhibition Place Announced to Support Prostate Cancer Canada

TORONTO (January 24, 2017) – Cycling enthusiasts have the opportunity to band together for a great cause while experiencing the Honda Indy Toronto like never before.
More

BRCA2 gene implicated in rare but lethal prostate cancer

January 9, 2017 – TORONTO, ON – Canadian scientists have discovered a link between an inherited mutation in the BRCA2 gene and a deadly form of prostate cancer.
More


Click here for news archive